Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
Ondansetron (Zofran) can affect the heart's electrical activity by prolonging the QT interval, which in rare cases may trigger a dangerous arrhythmia called torsades de pointes, and this risk rises with higher or more frequent doses, IV administration, low potassium or magnesium, existing heart disease, or other QT-prolonging medications. For most healthy people taking standard oral doses occasionally, the risk is low, but several important factors change that picture, including your dose, how often you use it, and warning signs like palpitations, fainting, or dizziness that should never be ignored. See below to understand which risk factors apply to you and when frequent use crosses into unsafe territory.
Because "too often" means something different for someone with a normal ECG than for someone on multiple medications or with an electrolyte imbalance, getting a clear read on your own situation matters before your next dose. Take a free, instant, online symptom check to help clarify what your symptoms may mean and decide whether to adjust with your doctor or seek urgent care.
Last reviewed for medical accuracy: 09/17/2026
Zofran (ondansetron) is a commonly prescribed medication for nausea and vomiting, especially after surgery or chemotherapy. It’s generally well tolerated, but like all drugs, it carries certain risks. One area of concern is its potential effect on the heart, especially when used frequently or at high doses. Below, we’ll break down what is known from credible sources, explain who’s most at risk, and offer practical steps you can take to stay safe.
Zofran works by blocking serotonin receptors (5-HT3) in the gut and central nervous system, which helps control nausea. However, it can also affect cardiac electrical activity:
While most people tolerate Zofran fine, certain factors make cardiac side effects more likely:
Be aware of symptoms that might signal a heart problem. If you experience any of these after taking Zofran, seek medical attention promptly:
If you and your doctor decide Zofran is right for you, consider these precautions:
If you’re unsure whether your symptoms merit a doctor’s visit—especially for mild palpitations or dizziness—you might start with a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide if you need immediate care, a sooner appointment, or simple home monitoring.
Zofran remains a valuable tool against nausea, but no medication is entirely risk-free. If you have any concerns—especially about your heart—talk openly with your healthcare provider. And remember, for any life-threatening or serious symptoms, you should always speak to a doctor or get emergency care right away.
(References)
* Guarino A, Ashkenazi S, Gendrel D, Lo Vecchio A, Shamir R, Szajewska H, European Society for Pediatric Gastroenterology, Hepatology, and Nutrition, European Society for Pediatric Infectious Diseases. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr. 2014 Jul;59(1):132-52. doi: 10.1097/MPG.0000000000000375. PMID: 24739189.
* Gummin DD, Moeller JR, Drendel AL. Reply. J Pediatr. 2017 Sep;188:312-313. doi: 10.1016/j.jpeds.2017.05.001. Epub 2017 May 29. PMID: 28571711.
* Weibel S, Rücker G, Eberhart LH, Pace NL, Hartl HM, Jordan OL, Mayer D, Riemer M, Schaefer MS, Raj D, Backhaus I, Helf A, Schlesinger T, Kienbaum P, Kranke P. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Epub 2020 Oct 19. PMID: 33075160; PMCID: PMC8094506.
* Ekobena P, Ivanyuk A, Livio F. [Pharmacovigilance update]. Rev Med Suisse. 2021 Jan 13;17(720-1):80-84. PMID: 33443836.
* Kim P, Masha L, Olson A, Iliescu C, Karimzad K, Hassan S, Palaskas N, Durand JB, Leung CH, Lopez-Mattei J. QT Prolongation in Cancer Patients. Front Cardiovasc Med. 2021;8:613625. doi: 10.3389/fcvm.2021.613625. Epub 2021 Feb 25. PMID: 33718445; PMCID: PMC7946823.
* Masarwe S, Shvartsur R, Hadar E, Betesh-Abay B, Peleg N, Azab AN. Ondansetron Use During Pregnancy: Birth Defects and Obstetric Outcomes. Clin Nurs Res. 2023 May;32(4):705-711. doi: 10.1177/10547738231159062. Epub 2023 Mar 13. PMID: 36912091.
* Singh K, Jain A, Panchal I, Madan H, Gupta A, Sharma A, Gupta S, Kostojchin A, Singh A, Sandhu IS, Mittal J, Bhogal L, Kolli ST, Bejugam VR, Chaturvedi S, Bhalla A, Piplani S. Ondansetron-induced QT prolongation among various age groups: a systematic review and meta-analysis. Egypt Heart J. 2023 Jul 3;75(1):56. doi: 10.1186/s43044-023-00385-y. Epub 2023 Jul 3. PMID: 37395900; PMCID: PMC10317942.
* Volmert B, Kiselev A, Juhong A, Wang F, Riggs A, Kostina A, O'Hern C, Muniyandi P, Wasserman A, Huang A, Lewis-Israeli Y, Panda V, Bhattacharya S, Lauver A, Park S, Qiu Z, Zhou C, Aguirre A. A patterned human primitive heart organoid model generated by pluripotent stem cell self-organization. Nat Commun. 2023 Dec 12;14(1):8245. doi: 10.1038/s41467-023-43999-1. Epub 2023 Dec 12. PMID: 38086920; PMCID: PMC10716495.
* Gerede A, Stavros S, Moustakli E, Potiris A, Orgianelis I, Zikopoulos A, Drakakis P, Domali E, Eleutheriades M, Nikolettos N. Hyperemesis in Pregnancy: Complications and Treatment. Med Sci (Basel). 2025 Aug 14;13(3). doi: 10.3390/medsci13030132. Epub 2025 Aug 14. PMID: 40843754; PMCID: PMC12372004.
* Pacheco LD, Clark SM, Fox K, Bauer ME, Clark SL. Use of Atropine, Ondansetron, and Ketorolac in Suspected Amniotic Fluid Embolism. Obstet Gynecol. 2026 Jun 1;147(6):780-784. doi: 10.1097/AOG.0000000000006095. Epub 2025 Oct 23. PMID: 41129822.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.